The HBLPSL is here to stay. But how high can it go? | Profit Explains

The debate between stakeholders about the tournament’s financial model is continuing even as it packs stadiums and makes good money

Must Read

AstraZeneca to buy EsoBiotec for up to $1 billion

Drugmaker AstraZeneca said on Monday it will buy biotechnology firm EsoBiotec for up to $1 billion. EsoBiotec’s Engineered NanoBody Lentiviral (ENaBL) platform can genetically modify...